Black Rock Inc. Meridian Bioscience Inc Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $7.41 Million - $7.94 Million	237,937 Added 3.25%	7,558,212 $251 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $2.97 Million - $3.22 Million	96,045 Added 1.33%	7,320,275 $231 Million
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $3.44 Million - $4.59 Million	-144,830 Reduced 1.97%	7,224,230 $220 Million
Q1 2022 May 12, 2022	SELL	$19.97 - $26.94 $736,194 - $993,143	-36,865 Reduced 0.5%	7,369,060 $191 Million
Q4 2021 Feb 10, 2022	BUY	$17.46 - $21.61 $2.1 Million - $2.6 Million	120,338 Added 1.65%	7,405,925 $151 Million
Q3 2021 Nov 09, 2021	SELL	$17.35 - $22.5 $2.2 Million - $2.86 Million	-127,024 Reduced 1.71%	7,285,587 $140 Million
Q2 2021 Aug 11, 2021	BUY	$18.01 - $28.32 $134 Million - $210 Million	7,412,611 New	7,412,611 $164 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.